(Midi does not prescribe this or other unapproved peptides.) What the science says: The existing evidence on BPC-157 is almost entirely based on animal (namely rat) data
The uses of BPC-157 for Digestive Disorders like IBS are listed below: Oral Administration : Taken orally to directly interact with gastrointestinal cells, supporting mucosal repair, reducing inflammation, and improving gut barrier integrity
Indeed, mitochondrial functional impairment causing increased lipid peroxidation and oxidative state is significantly increased in patients with Parkinsons disease, Downs syndrome and cancer, all diseases in which SD is more frequently observed
This assay measures light emission caused by the enzymatic reaction between ATP and luciferin-luciferase
Combining GHK-Cu with treatments like microneedling, as directed by a provider, may enhance results